Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer
- 24 July 2015
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 56 (1), 3-17
- https://doi.org/10.1002/mc.22338
Abstract
Protein‐coding genes account for only 2% of the human genome, whereas the vast majority of transcripts are noncoding RNAs including long noncoding RNAs. LncRNAs are involved in the regulation of a diverse array of biological processes, including cancer progression. An evolutionarily conserved lncRNA TUNA, was found to be required for pluripotency of mouse embryonic stem cells. In this study, we found the human ortholog of TUNA, linc00617, was upregulated in breast cancer samples. Linc00617 promoted motility and invasion of breast cancer cells and induced epithelial‐mesenchymal‐transition (EMT), which was accompanied by generation of stem cell properties. Moreover, knockdown of linc00617 repressed lung metastasis in vivo. We demonstrated that linc00617 upregulated the expression of stemness factor Sox2 in breast cancer cells, which was shown to promote the oncogenic activity of breast cancer cells by stimulating epithelial‐to‐mesenchymal transition and enhancing the tumor‐initiating capacity. Thus, our data indicate that linc00617 functions as an important regulator of EMT and promotes breast cancer progression and metastasis via activating the transcription of Sox2. Together, it suggests that linc00617 may be a potential therapeutic target for aggressive breast cancer.Keywords
This publication has 43 references indexed in Scilit:
- Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25Nature Communications, 2014
- Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast CancerPLOS ONE, 2014
- miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancerMolecular Cancer, 2014
- miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancerBreast Cancer Research, 2014
- LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S CheckpointMolecular Cell, 2014
- Triple-Negative Breast CarcinomaAmerican Journal of Clinical Pathology, 2014
- Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence EvolutionCell, 2011
- Insight into the heterogeneity of breast cancer through next-generation sequencingJCI Insight, 2011
- Heterogeneity in breast cancerJCI Insight, 2011
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammalsNature, 2009